QuantiFERON® TB GOLD’ s applications in the tuberculosis disease

QuantiFERON® TB GOLD’ s applications in the tuberculosis disease

<p><strong></strong><em>Background</em>. Tuberculosis is the most frequent cause of death from a single infectious agent in humans and remains a serious global health problem. The latent tuberculosis (LTBI) treatment can prevent progression to active disease. People inf...

Full description

Bibliographic Details
Main Authors:	Maria Saladino, Salvatore Nisticò, Annelisa Borelli, Vincenzina Caruso, Vilma Villella, Domenico Caruso, Maria Piccoli, Antonella Nicolazzo, Rosa Anna Leone
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-06-01
Series:	Microbiologia Medica
Subjects:	tuberculosis, QuantiFERON® TB GOLD, IFN-γ
Online Access:	http://www.pagepressjournals.org/index.php/mm/article/view/4662

Similar Items

QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01)

Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01)

Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients
by: Cengiz Çavuşoğlu, et al.
Published: (2021-05-01)

Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
by: Khaled H. Mohamed, et al.
Published: (2012-07-01)

Diagnostic utility of QuantiFERON-TB gold (QFT-G) in active pulmonary tuberculosis
by: Ahmed Anwar, et al.
Published: (2015-01-01)

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus
by: Elia Noemi Gallegos Morales, et al.
Published: (2017-05-01)

QuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children
by: Hossein Masoumi Asl, et al.
Published: (2015-09-01)

Comparative Evaluation of Standard E TB-Feron ELISA and QuantiFERON-TB Gold Plus Assays in Patients with Tuberculosis and Healthcare Workers
by: In Young Yoo, et al.
Published: (2021-09-01)

Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis
by: Ping-Chin Chang, et al.
Published: (2017-02-01)

The pros and cons of the QuantiFERON test for the diagnosis of tuberculosis, prediction of disease progression, and treatment monitoring
by: Elvis Ndukong Ndzi, et al.
Published: (2016-01-01)

Utility of QuantiFERON TB gold test in a south Indian patient population of ocular inflammation
by: Babu Kalpana, et al.
Published: (2009-01-01)

Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis
by: Mohammed Azghay, et al.
Published: (2016-03-01)

Comparison of QuantiFERON®TB Gold with tuberculin skin test to improve diagnostics and routine screening for tuberculosis infection among newly arrived asylum seekers to Norway
by: Askeland Winje, Brita
Published: (2008)

Comparison of the 2-step tuberculin skin test and QuantiFERON-TB Gold in-Tube test in the screening of latent tuberculosis infection in cancer patients
by: Hala A. Mohammad, et al.
Published: (2015-07-01)

Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions
by: Joel Monárrez-Espino, et al.
Published: (2014-11-01)

Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON<sup>®</sup> Gold Testing Useful?
by: Jessica Lovatt, et al.
Published: (2021-04-01)

Comparison of the tuberculin skin test and the QuantiFERON-TB Gold test in detecting latent tuberculosis in health care workers in Iran
by: Ehsan Mostafavi, et al.
Published: (2016-07-01)

Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study
by: Davaasambuu Ganmaa, et al.
Published: (2019-06-01)

Diagnostic utility of QuantiFERON-TB Gold and Xpert MTB/RIF combined with adenosine deaminase in tuberculous pleural effusion: a prospective study
by: Hassan Aref
Published: (2017-11-01)

Clinical Significance of Indeterminate QuantiFERON-TB Gold Plus Assay Results in Hospitalized COVID-19 Patients with Severe Hyperinflammatory Syndrome
by: Xavier Solanich, et al.
Published: (2021-02-01)

Testing for Mycobacterium tuberculosis infection using the QuantiFERON-TB GOLD assay in patients with comorbid conditions in a tertiary care endemic setting
by: Kiran Iqbal Masood, et al.
Published: (2020-02-01)

QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults
by: Benjawan Phetsuksiri, et al.
Published: (2018-10-01)

Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
by: Chun-Yu Cheng, et al.
Published: (2015-09-01)

Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burden
by: Thuli Mthiyane, et al.
Published: (2015-07-01)

QuantiFERON-TB Gold In-tube test for the diagnosis of active and latent tuberculosis in selected health facilities of Addis Ababa, Ethiopia
by: Selam Niguse, et al.
Published: (2018-05-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
by: Dominika Deborska-Materkowska, et al.
Published: (2018-04-01)

Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study
by: Hanan H Balkhy, et al.
Published: (2016-01-01)

Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus
by: Caroline Corbett, et al.
Published: (2020-10-01)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019-07-01)

Comparative study between using QuantiFERON and tuberculin skin test in diagnosis of Mycobacterium tuberculosis infection
by: Sohair A. Abdel-Samea, et al.
Published: (2013-01-01)

Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana
by: Gloria Ivy Mensah, et al.
Published: (2017-01-01)

Comparison of cost-effectiveness between the quantiferon-tb gold-in-tube and t-spot tests for screening health-care workers for latent tuberculosis infection
by: Shigeto Mukai, et al.
Published: (2017-01-01)

Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection
by: Cheleka A. M. Mpande, et al.
Published: (2021-08-01)

Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study
by: Carole Chedid, et al.
Published: (2021-02-01)

Predictive value of the tuberculin skin test and QuantiFERON-tuberculosis Gold In-Tube test for development of active tuberculosis in hemodialysis patients
by: Ekrem Cengiz Seyhan, et al.
Published: (2016-01-01)

Custo-efetividade da prova tuberculínica versus QuantiFERON-TB Gold-In-Tube no diagnóstico e tratamento da infecção latente tuberculosa em profissionais de saúde da Atenção Básica no Brasil.
by: Rafaela Borge Loureiro
Published: (2015)

Custo-efetividade da prova tuberculínica versus QuantiFERON-TB Gold-In-Tube no diagnóstico e tratamento da infecção latente tuberculosa em profissionais de saúde da Atenção Básica no Brasil.
by: Rafaela Borge Loureiro
Published: (2015)

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
by: Duc T. Nguyen, et al.
Published: (2018-03-01)

Assessment of Quanti FERON-TB Gold (In-Tube) Test in Tuberculosis Diagnosis
by: H Lashkardoost, et al.
Published: (2010-06-01)

Inverse correlation between serum complement component C1q levels and whole blood type‐1 interferon signature in active tuberculosis and QuantiFERON‐positive uveitis: implications for diagnosis
by: Benjamin Schrijver, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_2l5h78b5om28mqkmkba66jmq5l